SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-23-040450
Filing Date
2023-12-01
Accepted
2023-12-01 16:15:47
Documents
2
Period of Report
2023-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1701465332.html 3  
1 FORM 3 wk-form3_1701465332.xml 3 8163
2 EX-24.1 powerofattorney-afc.htm EX-24.1 5768
  Complete submission text file 0001628280-23-040450.txt   15513
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5777 CENTRAL AVE SUITE 102 BOULDER CO 80301
Business Address
Fox-Colis Aaron (Reporting) CIK: 0001963698 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21088 | Film No.: 231459709